THOMAS LINGELBACH
Pfizer to buy 8.1% stake in French vaccines company ValnevaValneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. ...
Covid-19 vaccine: Britain gives first European approval to Valneva shotThe go-ahead is the sixth COVID vaccine approval by Britain and comes even though London last September scrapped a 1.4 billion euro ($1.5 b...
New COVID vaccine shows 'strong immune response' in early UK trialsUK Health Secretary Matt Hancock said that the promising Phase I and II results mean that the Valneva vaccine, being developed at Livingsto...
- Intercell, an Austrian biotech group launches Jeev vaccine in IndiaIntercell has launched its Japanese encephalitis vaccine in India, and hopes to win approval for other Asian countries, it said on Thursday.
Load More- Intercell, an Austrian biotech group launches Jeev vaccine in India